CHI3L1 and Hepatic steatosis: Histological lipid grading together with Oil Red O staining results, and measurement of triglyceride levels suggest that altering Chi3L1 protein function with specific targeted agents to Chi3L1 may be beneficial in reducing hepatic steatosis as well.